Generics in Spain

Generics in Spain

Summary

Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The Spanish generics market had total revenues of $3.8bn in 2018, representing a compound annual growth rate (CAGR) of 2.7% between 2014 and 2018.
  • Market consumption volume increased with a CAGR of 0.6% between 2014 and 2018, to reach 40% of total pharma volume.
  • The share of the pharmaceutical market volume held by generics is relatively low in Spain when compared to other European countries, such as the UK and Germany, but various educational drives and government programs are encouraging doctors to expand use of generics.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Spain
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Spain
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Spain generics market with five year forecasts by both value and volume
Reasons to buy
  • What was the size of the Spain generics market by value in 2018?
  • What will be the size of the Spain generics market in 2023?
  • What factors are affecting the strength of competition in the Spain generics market?
  • How has the market performed over the last five years?
  • How large is Spain’s generics market in relation to its regional counterparts?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. Which players have been most successful in the recent past (1-3 years)?
7.3. What mergers or acquisitions have taken place in the last year?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Mylan N.V.
8.3. Pfizer Inc.
8.4. Esteve Group
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Spain generics market value: $ million, 2014-18
Table 2: Spain generics market volume: % of total pharma, 2014-18
Table 3: Spain generics market geography segmentation: $ million, 2018
Table 4: Spain generics market value forecast: $ million, 2018-23
Table 5: Spain generics market volume forecast: % of total pharma, 2018-23
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Mylan N.V.: key facts
Table 10: Mylan N.V.: Annual Financial Ratios
Table 11: Mylan N.V.: Key Employees
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: Annual Financial Ratios
Table 14: Pfizer Inc.: Key Employees
Table 15: Pfizer Inc.: Key Employees Continued
Table 16: Esteve Group: key facts
Table 17: Esteve Group: Key Employees
Table 18: Spain size of population (million), 2014-18
Table 19: Spain gdp (constant 2005 prices, $ billion), 2014-18
Table 20: Spain gdp (current prices, $ billion), 2014-18
Table 21: Spain inflation, 2014-18
Table 22: Spain consumer price index (absolute), 2014-18
Table 23: Spain exchange rate, 2014-18
List of Figures
Figure 1: Spain generics market value: $ million, 2014-18
Figure 2: Spain generics market volume: % of total pharma, 2014-18
Figure 3: Spain generics market geography segmentation: % share, by value, 2018
Figure 4: Spain generics market value forecast: $ million, 2018-23
Figure 5: Spain generics market volume forecast: % of total pharma, 2018-23
Figure 6: Forces driving competition in the generics market in Spain, 2018
Figure 7: Drivers of buyer power in the generics market in Spain, 2018
Figure 8: Drivers of supplier power in the generics market in Spain, 2018
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Spain, 2018
Figure 10: Factors influencing the threat of substitutes in the generics market in Spain, 2018
Figure 11: Drivers of degree of rivalry in the generics market in Spain, 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook